Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03204357 · ClinicalTrials.gov registry record · NA

Fresh Autologous Whole Blood Transfusion After Cardiopulmonary Bypass

A NA study of Cardiac Disease and Bleeding Postoperative, sponsored by University of Colorado, Denver.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT03204357 is a NA study of Cardiac Disease and Bleeding Postoperative that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 70 participants, below the 819-participant average among 24 other Cardiac Disease trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03204357, a NA study of Cardiac Disease and Bleeding Postoperative, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

Autologous blood transfused at the end of cardiopulmonary bypass will reduce total blood loss 24 hours after surgery and improve mitochondrial oxygen delivery measured by plasma succinate levels. The study design is a prospective randomized interventional trial of transfusion of fresh autologous whole blood versus standard of care expectant management of bleeding during elective cardiac surgery.

Interventions

  • OTHER Fresh Autologous whole Blood
  • OTHER Standard of Care Expectant management of bleeding

Study Locations (1)

Colorado

  • University of Colorado Hospital - Aurora

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2022-01-24
Est. Completion 2026-09
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT03204357

The ClinicalTrials.gov registry entry for NCT03204357 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 24 other Cardiac Disease trials with a reported enrollment target (91% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cardiac Disease appearing as the primary indexed condition, and to 2 interventions - of which Fresh Autologous whole Blood is the first listed.

NCT03204357 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT03204357 about?

NCT03204357 is a clinical study titled "Fresh Autologous Whole Blood Transfusion After Cardiopulmonary Bypass". Autologous blood transfused at the end of cardiopulmonary bypass will reduce total blood loss 24 hours after surgery and improve mitochondrial oxygen delivery measured by plasma succinate levels. The study design is a prospective randomized interventional trial of transfusion of fresh autologous wh...

What is the current status of trial NCT03204357?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2022-01-24. Estimated completion is 2026-09.

What conditions does trial NCT03204357 study?

This clinical trial studies the following conditions: Cardiac Disease, Bleeding Postoperative.

What interventions are being tested in trial NCT03204357?

The interventions under investigation include: Fresh Autologous whole Blood (OTHER), Standard of Care Expectant management of bleeding (OTHER).

Who is sponsoring clinical trial NCT03204357?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03204357 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiac Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.